Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 33, 2022 - Issue 1
Submit an article Journal homepage
194
Views
1
CrossRef citations to date
0
Altmetric
Articles

Ventilatory support in Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis

Kevin Phana Department of Dermatology, St George Dermatology and Skin Cancer Centre, Sydney, Australia
,
Lawrence J. Ohb Sydney Medical School, University of Sydney, Sydney, Australia;c Department of Otolaryngology, Head and Neck Surgery, Concord Repatriation General Hospital, New South Wales, Australia;d Department of Burns, Concord Repatriation General Hospital, New South Wales, Australia;e Department of Otolaryngology and Head and Neck Surgery, Canberra Hospital, Sydney, AustraliaCorrespondence[email protected]
,
Andrea Issler-Fisherb Sydney Medical School, University of Sydney, Sydney, Australia;d Department of Burns, Concord Repatriation General Hospital, New South Wales, Australia
,
Amshuman Raob Sydney Medical School, University of Sydney, Sydney, Australia;e Department of Otolaryngology and Head and Neck Surgery, Canberra Hospital, Sydney, Australia
,
Eugene H. Wongb Sydney Medical School, University of Sydney, Sydney, Australia;c Department of Otolaryngology, Head and Neck Surgery, Concord Repatriation General Hospital, New South Wales, Australia
&
Peter Maitzb Sydney Medical School, University of Sydney, Sydney, Australia;d Department of Burns, Concord Repatriation General Hospital, New South Wales, Australia
Pages 525-530 | Received 12 Apr 2020, Accepted 13 May 2020, Published online: 28 May 2020

References

  • Bastuji-Garin S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol. 1993;129(1):92–96.
  • Gerull R, Nelle M, Schaible T. Toxic epidermal necrolysis and Stevens–Johnson syndrome: a review. Critical care medicine. 2011;39:1521–1532.
  • Harr T, French LE, editors. Adverse cutaneous drug eruptions. Vol. 97, Stevens-Johnson syndrome and toxic epidermal necrolysis. Switzerland: Karger Publishers; 2012. p. 149–166.
  • Hsu DY, Brieva J, Silverberg NB, et al. Morbidity and mortality of Stevens–Johnson syndrome and toxic epidermal necrolysis in United States adults. J Invest Dermatol. 2016;136(7):1387–1397.
  • Frey N, Jossi J, Bodmer M, et al. The epidemiology of Stevens–Johnson syndrome and toxic epidermal necrolysis in the UK. J Invest Dermatol. 2017;137(6):1240–1247.
  • Diphoorn J, Cazzaniga S, Gamba C, REACT-Lombardia study group, et al. Incidence, causative factors and mortality rates of Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry. Pharmacoepidemiol Drug Saf. 2016;25(2):196–203.
  • Rzany B, Mockenhaupt M, Baur S, et al. Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990–1992): structure and results of a population-based registry. J Clin Epidemiol. 1996;49(7):769–773.
  • Kim H-I, Kim S-W, Park G-Y, et al. Causes and treatment outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in 82 adult patients. Korean J Intern Med. 2012;27(2):203.
  • Sekula P, Dunant A, Mockenhaupt M, RegiSCAR study group, et al. Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. J Invest Dermatol. 2013;133(5):1197–1204.
  • Fouchard N, Bertocchi M, Roujeau J-C, et al. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol. 2000;115(2):149–153.
  • Charlton OA, Harris V, Phan K, et al. Toxic epidermal necrolysis and Steven–Johnson syndrome: a comprehensive review. Adv Wound Care. 2019. DOI:https://doi.org/10.1089/wound.2019.0977
  • Rzany B, Hering O, Mockenhaupt M, et al. Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens–Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol. 1996;135(1):6–11.
  • de Prost N, Mekontso-Dessap A, Valeyrie-Allanore L, et al. Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation. Crit Care Med. 2014;42(1):118–128.
  • Bhullar HK, Aung AK, Graudins L, et al. Upper airway involvement in Stevens–Johnson syndrome and toxic epidermal necrolysis. Burns. 2020;46(3):682–686.
  • Lebargy F, Wolkenstein P, Gisselbrecht M, et al. Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study. Intensive Care Med. 1997;23(12):1237.
  • Palmieri TL, Greenhalgh DG, Saffle J, et al. A multicenter review of toxic epidermal necrolysis treated in US burn centers at the end of the twentieth century. J Burn Care Rehab. 2001;22:S65–S96.
  • Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy. 2004;59(8):809–820.
  • Ardern-Jones MR, Mockenhaupt M. Making a diagnosis in severe cutaneous drug hypersensitivity reactions. Curr Opin Allergy Clin Immunol. 2019;19(4):283–293.
  • Aberer W, Bircher A, Romano A, EAACI Interest Group on Drug Hypersensitivity. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy. 2003;58(9):854–863.
  • Xia W, Mao C, Luo X, et al. A 13‐year retrospective study evaluating the efficacy of using air‐fluidized beds for toxic epidermal necrolysis patients. Australasian J Dermatol. 2016;57(3):205–209.
  • Hermiz SJ, Diegidio P, Ortiz-Pujols S, et al. Life-threatening skin disorders treated in the Burn Center: impact of health care-associated infections on length of stay, survival, and hospital charges. Clin Plast Surg. 2017;44(3):597–602.
  • Creamer D, Walsh S, Dziewulski P, et al. UK guidelines for the management of Stevens–Johnson syndrome/toxic epidermal necrolysis in adults 2016. J Plast Reconstr Aesthet Surg. 2016;69(6):e119–e153.
  • Dalli RL, Kumar R, Kennedy P, et al. Toxic epidermal necrolysis/Stevens-Johnson syndrome: current trends in management. ANZ J Surg. 2007;77(8):671–676.
  • Smith SD, Dodds A, Dixit S, et al. Role of nanocrystalline silver dressings in the management of toxic epidermal necrolysis (TEN) and TEN/Stevens-Johnson syndrome overlap. Australas J Dermatol. 2015;56(4):298–302.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.